Okapi Sciences was a Belgium based biopharmaceutical company focused on the licensing, development and commercialization of innovative antiviral drugs for livestock and pets.

Okapi was started by and spun out from the University of Leuven (KU Leuven). Okapi was acquired by Aratana Therapeutics Inc. in 2014.

Company: Okapi Bioscienes
Fund: I
Status: realized
Team member: Harrold van Barlingen
Technology: therapeutics